Clinical Case Series - 23BCI - Question 1

How do you determine which patients will benefit from extending endocrine therapy from 5 to 10 years?

I use clinical risk features

I make the decision based on tolerability/side effects

I order a BCI test

I extend for all patients

I do not extend for any patients

{"name":"Clinical Case Series - 23BCI - Question 1", "url":"https://www.poll-maker.com/QQVD16FK0","txt":"How do you determine which patients will benefit from extending endocrine therapy from 5 to 10 years?","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}

Tools: Poll Maker | Quiz Maker | Super Surveys